Центральная серозная хориоретинопатия: навигационное лечение NAVILAS 577S

Abstract

Central serous chorioretinopathy (CSC) is a common retinal disease whose etiology and pathogenesis remain largely ambiguous. Subthreshold micropulsed laser (SMILV) treatment has been intensively used for the treatment of CSC over the last decade. Purpose. To develop a method for the treatment of macular edema in CSC by subthreshold micropulse laser exposure on the Navilas 577s navigation laser system. Material and methods. The study included 65 subjects (65 eyes), 32 to 54 years of age, with acute and chronic CSC. All patients underwent standard ophthalmological examination and additional examinations including: optical coherence tomography (OCT) Topcon DRI OCT Triton and OCT-A, Maia microperimetry, autofluorescence of the eye with Zeiss Clarus 500 wide angle imaging system. Treatment was performed by SMILV using Navilas 577s system in patients with acute and chronic forms. Results. The main criteria for the effectiveness of the treatment were: an increase in maximum corrected visual acuity (BCVA), a decrease in neuroepithelial detachment (ONE) and its attachment speed, a decrease in retinal thickness and an improvement in photosensitivity (SF). Conclusion. In the treatment of CSC, preference is given to SMILV exposure, which has a physiotherapeutic effect without visible damage to the retina. The Navilas 577s navigation laser system achieves the highest precision and efficiency in retinal laser treatment, while significantly reducing procedure time and patient discomfort. Keywords: central serous chorioretopathy (CSC), subthreshold micropulse laser exposure (SML), neuroepithelial detachment, Navilas 577s.